Australia's Inoviq rises on Chinese patent for lung cancer test

Inoviq

24/12/2021 01:13

** Shares of medical diagnostics co Inoviq Ltd  IIQ.AX  rise
as much as 4.2% to A$1.115, their biggest intraday pct. gain
since Dec. 17
    ** Co says it has been granted a Chinese patent covering
lung cancer diagnosis  urn:newsml:reuters.com:*:nASX6Ysrsx
    ** Patent protects co's BARD1 autoantibody test for
diagnosis of lung cancer in China
    ** Stock up 57.4% YTD, as of last close

 (Reporting by Arundhati Dutta in Bengaluru)
 ((Arundhati.Dutta@thomsonreuters.com;))